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Abstract
Background: There are sparse data on genetic, epigenetic and vitamin D exposure in African Americans (AA) with colon
polyp. Consequently, we evaluated serum 25(OH) D levels, vitamin D receptor (VDR) polymorphisms and the methylation
status of the tumor suppressor gene dickkopf homolog 1 (DKK1) as risk factors for colon polyp in this population.
Methods: The case-control study consisted of 93 patients with colon polyp (cases) and 187 healthy individuals (controls) at
Howard University Hospital. Serum levels of 25(OH)D (including D3, D2, and total) were measured by liquid
chromatography-mass spectrometry. DNA analysis focused on 49 single nucleotide polymorphisms (SNPs) in the VDR
gene. Promoter methylation analysis of DKK1 was also performed. The resulting data were processed in unadjusted and
multivariable logistic regression analyses.
Results: Cases and controls differed in vitamin D status (D3,50 nmol/L: Median of 35.5 in cases vs. 36.8 in controls nmol/L;
P=0.05). Low levels of 25(OH)D3 (,50 nmol/L) were observed in 86% of cases and 68% of controls and it was associated
with higher risks of colon polyp (odds ratio of 2.7, 95% confidence interval 1.3–3.4). The SNP analysis showed no association
between 46 VDR polymorphisms and colon polyp. The promoter of the DKK1 gene was unmethylated in 96% of the
samples.
Conclusion: We found an inverse association between serum 25(OH)D3 and colon polyp in AAs. VDR SNPs and DKK1
methylation were not associated with colon polyp. Vitamin D levels may in part explain the higher incidence of polyp in
AAs.
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Introduction
Colorectal cancer is the third most common cancer in the
United States [1]. It has higher incidence and mortality in African
Americans (AA) than in other racial groups. Most colorectal
cancers arise from adenomas, in a process described as the
adenoma-carcinoma sequence [2,3]. Like other cancers, initiation
and progression of CRC are associated with accumulation of
changes in genetic and epigenetic factors. Earlier studies
demonstrated that CRC mortality is highest in populations that
are least exposed to sunlight [4,5]. As a consequence, they
hypothesized that vitamin D, which is produced in the skin as a
response to UV-B radiation, may have a protective role against
colorectal cancer. Several studies have been done on the
association of vitamin D and the development of colorectal
cancer, which confirmed Garland and Garland’s hypothesis
[4,5,6]. Diets that are rich in lipids and low in calcium and
vitamin D are strongly associated with high risk of colon cancer
[6,7]. Although the effects of vitamin D on the development of
colon cancer have been extensively studied in whites [8,9]there are
few studies done in the African American population [10].
Studies have shown that diet and chemoprevention can
modulate the progression of colon cancer [6]. Indeed, a diet of
low calcium and vitamin D and elevated lipids can induce colonic
tumors [7,11]. However, these abnormal growths can be inhibited
with supplements of calcium and vitamin D, hence demonstrating
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cancer prevention [12].
Studies have attempted to assess the effects of various single
nucleotide polymorphisms (SNPs) of the vitamin D receptor (VDR)
gene on the development of colon cancer. This gene is located on
chromosome 12 and contains 9 exons [13]. The initial hypothesis
is that variations in VDR expression or VDR protein sequence
cause changes in levels of vitamin D. Since other studies suggest
and here we confirm that vitamin D levels are associated with
polyp or cancer risk, we test a composite hypothesis that variations
in VDR are associated with polyp risk.
More than 470 SNPs in the VDR gene have been reported
[14,15,16,17,18,19,20,21]. Currently, the most extensively studied
polymorphisms are the following: 1) rs10735810 or Fok1 in exon
2, 2) rs1544410 or Bsm1 in intron 8, 3) rs731236 or Taq1 in exon
9, 4) rs7975232 or Apa1 in intron 8, 5) rs757343 or Tru91 in
intron 8, and 6) the poly (A) mononucleotide repeat in the 39-
UTR. The roles of the polymorphisms depend on their locations
[18]. For example, Fok1 is within the DNA binding domain, near
the 59end, and the rest of the SNPs are in the 39-UTR region
within the ligand-binding domain. While the effect of most of these
polymorphisms is unknown, the Fok1 polymorphism is known to
lead to a TRC nucleotide substitution and a change in the start
codon in exon 2 at the 59 end of the VDR gene [22]. This new site
(‘‘f’’ allele) promotes the initiation of translation from the first
codon instead of the second codon (‘‘F’’ allele). The result is a
protein that is 3 amino acids longer. The f allele product is a less
potent transcriptional activator [23]. Conversely, the absence of
Fok1 site results in a shorter VDR protein with higher
transcriptional and biological activities [15]. Much remains to be
elucidated with respect to the physiological effects of VDR
polymorphisms.
One human gene that has been previously connected to both
vitamin D levels and pathways involved in CRC is dickkopf
homolog 1 (DKK1). The unusual gene name came about because
orthologs of the human gene were discovered in lower organisms,
the first one being the frog (Xenopus). DKK1 encodes a secreted
protein involved in embryonic induction and in antagonizing the
Wnt pathway [24]. Human DKK1 takes part in a host of complex
cellular processes in different cell types. According to Pendas-
Franco et al [24], this protein induces the proliferation of human
adult bone marrow stem cells, inhibits osteoblastic differentiation,
stimulates the differentiation of preadipocytes and inhibits the
proliferation of crypt progenitor cells, induced by the transcrip-
tional activity of the b-catenin/T cell factor complex in the small
intestine and colon of mice. 1,25 (OH) D3 up-regulates the
transcriptional activity of DKK1, thus connecting vitamin D levels
to expression of a gene whose encoded protein function in an
important pathway in the development of colorectal cancer. A
common mechanism by which expression levels of genes are
known to be inappropriately lowered in cancer is methylation of
the promoter. Therefore, we evaluated whether DKK1 is
methylated unusually often in tumors from the cases used in our
case-control study of vitamin D levels.
According to Davis et al. [15], unlike serum concentrations of
1,25(OH) D that are ‘‘tightly regulated and do not vary with
geographic latitude or race’’, serum concentrations of 25(OH)D
are lower amongst persons with dark pigmentation and decrease as
one moves away from the equator. Moreover, the melanin in
people with darker complexion acts as a protective barrier against
UV rays. As a consequence, vitamin D synthesis is considerably
hindered [4,5]. In addition to skin color and geographical location,
vitamin D synthesis is also determined by age (the ability to
produce vitamin D decreases with age), season of the year, fat
malabsorption syndromes (e.g. cystic fibrosis), skin covering
(sunscreen and clothing) and the level of air pollution [25]. Body
mass index (BMI) is also associated inversely with the level of
vitamin D in the serum. It is believed that vitamin D is sequestered
in ‘‘subcutaneous fat’’ in obese individuals [26].
In this study, we suggest that the African American population
treated at the Howard University Hospital (HUH, located in
Washington, D.C.) is more prone to developing colon polyp, partly
due to their vitamin D deficiency related to skin color, the
geographic location and other unknown factors. The first objective
of this study was to determine if the African Americans at HUH
have a high frequency of vitamin D deficiency (defined as
25(OH)D,50 nmol/L) [5]. Secondly, was there an association
between vitamin D deficiency and colon polyp and other variants
such as sex, race, age, BMI, season of blood collection, alcohol and
smoking status [27,28,29,30]. Thirdly, the study assessed whether
polymorphisms in the VDR gene are also polymorphic in the AA
population at HUH and if so, whether any of them are associated
with colon polyp. Lastly, we evaluated whether the DNA
methylation status of the tumor suppressor gene DKK1 is
associated with the vitamin D deficiency and colorectal adenoma
in AA.
Materials and Methods
Ethics Statement
This study was approved by the Howard University Institutional
Review Board, and written, informed consent was obtained from
all participants.
Patients
The blood specimens were obtained based on two previous
studies (between 2000 and 2004; 2008 and 2009) from African-
American patients undergoing colonoscopy at Howard University
Hospital. The total number of patients enrolled in this study was
280, including 93 cases (colon polyp) and 187 controls (healthy
controls with no family history of CRC). Study participants were
excluded if they any of these criteria: HIV infection, recent surgery
or bone fracture, pregnancy or kidney disease. In both recruitment
periods serum was isolated from fasting blood. We used the same
criteria for case and controls. Samples were centrifuged for
10 minutes at a speed of 4436ga t4 uC. Serum were stored at
220uC for later vitamin D quantitation. Both cases and controls
were collected in the same time intervals, in the same clinic, and
processed under the same protocol prior to analysis. The time
from venipuncture to serum processing was approximately
2 hours. DNA was also isolated from whole blood samples using
Qiagen FlexiGene Kit (Qiagen, Hilden, Germany).
Vitamin D quantitation
250–500 ml aliquots of blood serum were shipped on dry ice to
Massachusetts General Hospital (MGH) (Boston, MA) for serum
25 (OH) D measurements by liquid chromatography-mass
spectrometry (LC-MS). This technique is replacing DiaSorin
radioimmunoassay as the criterion standard [31]. The method
involves the use of an isotope dilution: the deuterated stable
isotope d3-25-hydroxyvitamin D. LC-MS assay was optimized in
an MGH laboratory based on published procedures [32]. The
limit of detection was 5 nmol/L for D2 and 7.5 nmol/L for D3.
The between-run coefficient of variation (i.e. CV) for a quality
control serum containing a total vitamin D concentration of
57 nmol/L was 7.5%. For all primary analyses, a prior categories
were used based on clinically defined cut points introduced by
Garland et al 2009 ,50 nmol/L: insufficiency [5].
Vitamin D and Risk of Colon Adenoma
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To determine tagging SNPs, genotyped VDR polymorphisms in
the Yoruba population were collected from public databases
including Hapmap, dbSNP and Seattle SNPs. SNPs in the coding,
non-coding , and 59 and 39 untranslated regions of VDR (46586959
to 46521297 Mb) were input into the program LDSelect [33] to
determine tagging SNPs with minor allele frequencies.0.05 and
r
2.0.8. The allele frequency requirement was applied first to the
public data to select some SNPs. That the public Yoruba samples
have a high minor allele frequency does not imply that the minor
allele frequency must be .0.05 in the HUH AA population.
Previously tested VDR functional SNPs Taq1 and Fok1 were also
genotyped. In total, we genotyped 57 VDR tagging SNPs were
genotyped in this study. iPLEX assays were designed using the
Sequenom (San Diego CA), Assay Design software. Primer
sequences for PCR and single-base extension are available on
request. Multiplex PCR was performed to amplify 5–10 ng of
genomic DNA extracted from the surgical specimens. PCR
reactions were treated with shrimp alkaline phosphatase (SAP) to
neutralize unincorporated dNTPs. A post-PCR single-base
extension reaction was performed for each multiplex reaction
using concentrations of 0.625 mM for low-mass primers and
1.25 mM for high-mass primers. Reactions were diluted with
16 mLo fH 2O and fragments were purified with resin, spotted
onto Sequenom SpectroCHIP microarrays and scanned by
MALDI-TOF mass spectrometry. Individual SNP genotype calls
were generated using Sequenom TYPE software which automat-
ically calls allele-specific peaks according to their expected masses.
Among the genotyped SNPs, 49 had minor allele frequencies
.0.05 in the HUH AA population.
Methylation analysis of DKK1 gene
Methylation-specific quantitative real time PCR (Q-MSP) was
used to quantify the amount of methylated DNA in the promoter
of DKK1. DNA was isolated using the Qiagen, Germantown, MD)
FlexiGene kit from whole blood samples. For each sample, 500 ng
of DNA was modified using sodium bisulfite treatment (Zymo
Research, Irvin CA), following the manufacturer’s instructions.
During this step, unmethylated cytosines, in CpG islands, are
modified into uracils, while methylated cytosines remain the same.
The immortalized cancer cell line SW48 and normal white blood
cells were respectively used as positive and negative controls for
DNA methylation. Real-time PCR was performed to amplify 3 ng
of DNA modified with bisulfite. The real-time PCR ABI 7500
instrument (Applied biosystems Carlsbad, California) with a
melting curve analyzing system was used. Each PCR reaction
contained 12.5 mlo fR T
2 SYBR GREEN/ROX qPCR Master
Mix (SA, Bioscience Corporation) with 0.5 mM of primers in a
total volume of 20 ml. The fully methylated DNA extracted from
SW48 cells was used as standard DNA for absolute quantification
[34]. Primers were designed according to a published protocol
[34], which also specified the PCR conditions and number of
cycles.
Statistical analysis
Serum concentrations of vitamin D in the study samples were
reported as median (interquartile range). We used the natural log
transformation for vitamin D concentration. Vitamin D levels and
other continuous variables between cases (colon polyps) and
normal controls were compared using the student’s t-test.
Categorical variables between cases and controls were compared
with Chi-square tests. In a multiple logistic regression analysis the
odds ratios (OR) of vitamin D levels on colon polyp were
computed after adjusting for the effect of age, sex, season of
sampling, BMI, smoking, and alcohol consumption. We also used
the distribution of vitamin D in controls to calculate quartiles of
serum 25-hydroxyvitamin D concentration and the effect of
different serum vitamin D level on risk of the colon polyp. In the
final analysis, a Bonferoni correction was applied to any nominally
significant results. All analyses were performed by Stata 10.1
(StataCorp, College Station, TX). P values of 0.05 or lower were
considered statistically significant. Tests of association between
genotype and the polyp phenotype were done with the software
PLINK [35].
Results
Association of vitamin D3 with risk of colon polyp
The possibilities of association of gender, alcohol, smoking and
serum 25(OH)D level on the risk of developing colon polyp were
examined in a cohort of 280 AA individuals. There were 93 cases
with colon polyp and 187 normal colon controls. The colon polyps
sample group consisted mainly of two types of neoplasms: tubular
adenomas, which represented 76% of samples, and hyperplastic
polyps, 16% of the case population. The remaining samples were
cases of mixed polyps (tubular, tubovillous, and villous). The
distribution of demographic variables and vitamin D concentra-
tion in cases and controls was determined (Table 1). Based on the
data (Table 1), median vitamin D levels in cases and controls were
41.2 and 41.4 nmol/L, respectively. The median ages of cases and
controls were 59 and 60 years, respectively. Frequency of current
and past smoking was not different among the cases and controls
but cases had higher frequency of current smoking (20% vs. 9% in
controls, P=0.01). Both cases and controls had deficiency of
vitamin D, whose sources are diet and food supplements, as
opposed to vitamin D3 that is also synthesized in the skin during
sun exposure. Vitamin D3 concentration was lower in polyp cases
(P=0.05). By using the reference range (vitamin D levels 75–
199 nmol/L as sufficient), both groups were deficient [36]. The
median vitamin D2 concentration for cases and controls was 1.7
and 2.3 nmol/L (Table 1), respectively. For vitamin D3, the
medians for patients and controls were 35.3 and 36.8 nmol/L,
respectively, which shows Vitamin D deficiency. There were no
significant differences between cases and controls on the following
variables: age, body mass index, gender distribution, alcohol
consumption, 25(OH)D2 and total Vitamin D concentration.
Total 25(OH)D and its association with seasonal variation
The concentration of total 25(OH)D3 in the sample pool across
the seasons of the year was measured (Figure 1). Total 25(OH)D
concentrations were marginally higher in winter and summer and
were lower in spring and fall (P=0.06).
Association between vitamin D concentrations and risk
of colon polyp
Based on the range of vitamin D concentrations in controls, 4
different quartiles were generated. The odds ratios (OR) of
different vitamin D concentrations on the risk of colon polyps was
assessed (Table 2). No significant difference was found between the
cases and controls, when looking at various concentrations of
25(OH)D2, 25(OH)D3 and total 25(OH)D. However, the results,
point towards a general tendency of lower risk of polyps for the
higher quartiles of total vitamin D and vitamin D3. The
association of total 25(OH)D and 25(OH)D3 with the risk of
colon polyp was analyzed (Table 3). Levels of 25(OH)D that are
less than 50 (nmol/L) are in 83% of cases and only 69% of controls
(P=0.018). Similarly, 86% of cases and 68% of controls had
insufficient 25(OH)D3 levels (P=0.002). The latter difference
Vitamin D and Risk of Colon Adenoma
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season, smoking, and alcohol usage. This remains significance
even after Bonferoni correction. If the samples are partitioned by
season, then spring (P=0.07), summer (P=0.07), and fall
(P=0.08) all show a similar trend towards significance, but winter
(P=0.9) does not. The comparisons for any specific season are not
significant because the sample sizes become too small when the
total sample set of 93 cases and 187 controls is partitioned by
season. This indicates that lower levels of 25(OH)D3 and total
25(OH)D are associated with higher risks of colon polyp (with
50 nmol/L used as the threshold for deficiency).
DNA Methylation of DKK1 promoter is not associated
with the risk of colon polyp
DNA methylation in the DKK1 promoter was quantified using
the Q-MSP method in 280 samples. In this pool of samples, the
DKK1 promoter was not methylated. There were 62, 65 and 3
patients with ,1%, 1–10%, and .10% DKK1 methylation in
control vs. 37, 31, and 1 patients in cases, respectively. Out of 93
colon polyp samples, only 3 individuals showed methylation level
higher than 20%.
VDR SNPs not associated with risk of colon polyp
Forty-nine of the 57 VDR SNPs genotyped had a minor allele
frequency .0.05 in the study population (supporting information
Table S1). No significant association was found between the SNPs
and the risk of colon polyp in the patients’ pool. Moreover, the
allele frequencies of each SNP were similar in cases and controls.
Some studies done subsequent to our choice of SNPs indicate that
other SNPs in the VDR gene are polymorphic in African
Americans [37,38,39]. These additional SNPs are sufficiently
close to at least some of the SNPs we genotyped and hence would
be expected to be in strong linkage disequilibrium with SNPs we
genotyped.
Table 1. Distibution of demographic variables and vitamin D concentration in cases (colon adenoma) and controls.
Cases (n
1=93) Controls (n
1=187) P value
Age 59 (52–68) 60 (52–66) 0.68
Male, n (%) 49 (53%) 81 (44%) 0.15
Current or past smoker, n (%) 40 (44%) 63 (332%) 0.11
Current or past alcohol drinker n (%) 45 (50%) 97 (53%) 0.71
BMI (kg/m
2) 28 (24–34) 29 (26–33) 0.66
D2 concentration (nmol/L) 1.7 (1.0–5.6) 2.3 (1.3–4.7) 0.34
D3 concentration (nmol/L) 35.3 (26.2–45.4) 36.8 (25.2–55.7) 0.05
Total Vit D concentration (nmol/L) 41.2 (30.2–51.8) 41.4 (29.4–65.6) 0.49
Results are in median (inter-quartile) unless otherwise indicated.
1Number of cases (n=4) and controls (n=3): fluctuates (e.g. n=90–93) due to missing value for some samples.
doi:10.1371/journal.pone.0025314.t001
Figure 1. Total 25(OH)D and its association with seasonal variation. The concentration of total 25(OH)D in the colon polyp (n=93) and
normal (n=187, healthy controls with no family history of CRC) samples across the seasons of the year was measured by liquid chromatography-mass
spectrometry. Total 25(OH)D concentrations were marginally higher in winter and summer and were lower in spring and fall (P=0.06).
doi:10.1371/journal.pone.0025314.g001
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Prior studies have shown that the level of serum 25(OH)D is
inversely correlated with the rate of colorectal cancer among white
Americans [5,6,40,41]. In the present study, we demonstrated that
serum total 25(OH)D and 25(OH)D3 concentrations among
African Americans patients at Howard University Hospital
(HUH) are inversely associated with the risk of colon polyps. An
insufficient amount of vitamin D (,50 nmol/L) associates with
higher chances of developing colon polyps [5]; Chan, 2010 #47}.
According to the reference range, vitamin D levels ,50 nmol/L in
the HUH sample group are on the lower end or insufficient. These
results can be explained by the fact that today’s lifestyle requires
most people to work indoors. Consequently, if people do not
expose themselves to the sun daily, and do not fortify their diets or
supplement with vitamins, they run the risk of vitamin D
deficiency. This is likely what happened in many AA individuals
enrolled in this study [42,43,44]. Moreover, the darker complex-
ion of AA individuals may exacerbate this deficiency because of
the melanin screen effect [4,5,40,41]. Other studies showed that
diets and chemoprevention can modulate the progression of colon
cancer [6]. Indeed, a diet of low calcium and vitamin D and
elevated lipids can induce colonic tumors [7,11]. Although the
effects of vitamin D on the development of colon cancer have been
extensively studied in white Americans [8,9], there are sparse data
from the African American population [10] to determine the levels
of 25-hydoxyvitamin D (25[OH]D) in the serum of healthy vs. ill
individuals.
Earlier studies demonstrated that cancer mortality had the
highest rate in the populations that were least exposed to sunlight
[4,5]. As a result, they hypothesized that vitamin D, which is
produced in the skin as a response to UV-B radiation, may have a
protective role against colorectal cancer. Since then, several studies
have been done on the association of vitamin D and the
development of colorectal cancer, which confirmed Garland and
Garland’s hypothesis [4,5,6]. It is not clear why total 25(OH)D
concentrations were a bit higher in winter, even though this level
was higher in summer and lower in spring and fall. AA may have
different environmental exposures including diet that might
change the composition and the activities of the intestinal
microbiota, in turn affecting fecal genotoxicity/mutagenicity that
is thought to be associated with carcinogenesis. Mai et al reported
an increased intake of heterocyclic amines (HCA) and a decreased
dietary intake of vitamins including vitamin D (p,0.05) in AA that
correlated with differences in fecal microbiota composition [10].
Dietary habits of AA, including increased HCA intake and
decreased vitamin D intake might at least partially contribute to
CRC through modifications of gut microbiota composition that
result in changes of the intestinal milieu [10]. In the human body,
vitamin D3 is needed for many physiological activities. Conse-
quently, it is found in larger concentrations than vitamin D2.
Indeed, Houghton et al. cite three factors explaining the ‘‘better
bio-efficacy’’ of vitamin D3: more affinity to vitamin D binding
proteins, small variation in chemical structure and hepatic
hydroxylases [45]. The D2 form has been distinguished from the
D3 form in various epidemiological studies [27]. Measurement of
serum vitamin D may have some degree of errors. A CV of 7.5%
in our assay indicates a mild imprecision. This may cause some
noise to our relationships and especially decrease our power to find
significant relationships.
The strengths of our study include the uniqueness of our
population and that we are basing our comparisons on serum
Table 2. Odds ratio (95% CI) of different serum 25-hydroxyvitamin D concentration in risk of colon polyp.
1
st quartile
(n=69)
2
nd quartile
(n=71)
3
rd quartile
(n=70)
4
th quartile
(n=70) P for test of trend
25(OH)D2 (nmol/L) ,1.0 1.0–1.7 1.8–4.7 .4.7
Unadjusted OR 1 0.9 (0.4–1.8) 0.5 (0.3–1.1) 0.8 (0.4–1.6) 0.3
Adjusted OR
1 1 0.9 (0.4–2.0) 0.6 (0.3–1.2) 0.9 (0.4–1.9) 0.5
25(OH)D3 (nmol/L) ,25.3 25.3–35.9 36.0–50.4 .50.4
Unadjusted OR 1 1.5 (0.8–3.1) 1.9 (0.9–3.8) 0.5 (0.2–1.2) 0.2
Adjusted OR
1 1 1.5 (0.7–3.2) 1.8 (0.9–3.9) 0.6 (0.2–1.3) 0.3
25(OH)D total (nmol/L) ,29.5 29.5–41.2 41.3–57.7 .57.7
Unadjusted OR 1 1.4 (0.7–2.8) 2.0 (1.0–4.0) 0.5 (0.2–1.1) 0.3
Adjusted OR
1 1 1.4 (0.7–3.1) 1.9 (0.9–4.1) 0.6 (0.3–1.4) 0.4
1Adjusted for effect of age, sex, BMI, season, smoking and alcohol usage.
doi:10.1371/journal.pone.0025314.t002
Table 3. Odds ratio (95% CI) of insufficient vitamin D status in risk of colon polyp.
Cases
(N=92)
Controls
(N=186) Unadjusted Adjusted
1
OR (95% CI) P value OR (95% CI) P value
Total 25(OH)D ,50.0, no (%) (nmol/L) 76 (83) 128 (69) 2.1 (1.1–3.9) 0.018 1.7 (0.9–3.4) 0.10
25(OH)D3 ,50.0, no (%) (nmol/L) 79 (86) 127 (68) 2.8 (1.5–5.5) 0.002* 2.6 (1.3–5.2) 0.007*
1Adjusted for effect of age, sex, BMI, season, smoking and alcohol usage.
*Significant after Bonferoni correction.
doi:10.1371/journal.pone.0025314.t003
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D intake as deduced from diet questionnaires. One weakness is the
small sample size. To obtain significant results for D2 and D3,w e
would need a much larger sample (.1000 subjects) in each group
for the calculations in Table 1, We are pursuing this goal with a
more comprehensive analysis in the near future. At the moment,
our calculations show that the value for Vitamin D2 and total
Vitamin D are not significantly different between the two groups
in our population. We are joining efforts with other centers with
interest in colon cancer in African Americans to have samples
from other areas of the United States for our future studies.
With respect to promoter methylation of the tumor suppressor
gene DKK1 and 46 SNPs in the VDR locus, no association was
found with risk of colon cancer. We found there are no
associations between the methylation and Vitamin D consistent
with Penda ´s-Franco study [24]; as seen in Europeans, DKK1
methylation in African Americans is not directly associated with
vitamin D.
According to Davis et al, over 470 VDR SNPs are known [15].
Their distribution and frequency vary among ethnic groups. Most
of the work done on VDR polymorphisms has been conducted in
Caucasian populations and has focused on the six SNPs
mentioned in the introduction. Two of them, Fok1 and Taq1,
have been associated with breast cancer risk [14]. However,
Barroso et al [14] emphasized that the results of their study should
be replicated on a larger samples. In our study, Taq1 had no
significant association with risk of colon polyp; Fok1 was
genotyped but had too low a minor allele frequency in our study
population to be tested for association. Moreover, none of the
comprehensive tagging SNPs in VDR were significantly associated
with colonic polyps. Diet could be a modifier factor in the VDR
analysis, but we did not have complete diet information on the
current patients.
Causal inference from a case-control study should be drawn
with extreme caution. Case-control studies are prone to a range of
bias, including selection bias, confounding bias and lack of
temporality. In this study, we tried to reduce the effect of
confounding variables by multivariate analysis. The potential
sources of selection bias were reduced by selecting the patients and
controls from same race and institute, and especially the same
clinic.
In sum, we found an inverse association between serum
25(OH)D3 and colon polyp in AA. VDR SNPs and DKK1
methylation were not associated with colon polyp. The novelty
of this study is due to its unique population and their high risk of
CRC. Since pigment has been associated with vitamin D levels
and vitamin D levels have been associated with CRC, studies
focused on an AA population are especially needed to clarify these
relationships. Overall, the low Vitamin D levels in AA may in part
explain the higher incidence of polyp in AA. Larger studies of the
AA community involving more of the genetic elements involved in
the Vitamin D pathway/metabolism are needed to shed more
light on the Vitamin D implication in colonic oncogenesis in this
population.
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